Multiple effects of probiotics on different types of diabetes: a systematic review and meta-analysis of randomized, placebo-controlled trials
The DOI matches its Crossref record; 46 of the 49 references it cites were found in a registry or an index.
Abstract
Background: A systematic review and meta-analysis was designed to evaluate the effect of probiotics on diabetes and its associated risk factors. Methods: We systematically searched the Cochrane Library, PubMed, EMBASE and Web of Science to June 2016. We also hand-searched the citation lists of included studies and previously identified systematic reviews to identify further relevant trials. Our primary outcome variables included glucose, glycated hemoglobin (HbA 1c) and insulin. The pooled standardized mean difference was used to compare the effect between the probiotics and controlled groups, and the pooled standardized mean difference effect size with a 95% confidence interval (CI) was estimated using a random-effect model. Heterogeneity was assessed with Cochran’s Q and Higgins I2 tests. Two reviewers assessed trial quality and extracted data independently. The analysis and bias for each included study was performed and assessed using Review Manager 5.2. Results: Eighteen randomized, placebo-controlled studies (n=1056 participants, 527 consuming probiotics, 529 not consuming probiotics) were included for analysis. Comparing the probiotics groups with the control groups, there were statistically significant pooled standardized mean differences on the reduction of glucose (−0.61, 95% CI −0.98, −0.24; p=0.001), insulin (−0.49, 95% CI −0.93, −0.04; p=0.03) and HbA 1c(−0.39, 95% CI −0.60, −0.19%; p=0.0001). Subgroup analysis also indicated statistical significance on the reduction of low-density lipoprotein cholesterol (LDL-C) in non-type 2 diabetes (non-T2DM) mellitus patients with diabetes, for the pooled standardized mean difference was −0.29 (95% CI −0.54, −0.04; p=0.02). Conclusions: Probiotics may have beneficial effects on the reduction of glucose, insulin and HbA 1c for diabetes, especially for T2DM mellitus patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, a separate analysis of studies conducted within the United States showed a 25% increase in risk of accidents, whereas studies conducted outside the United States showed no increased risk.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1695]
In the citing paper
“Taken as a whole, individuals with DM do not have a significantly increased risk of motor vehicle accidents compared with drivers without DM.”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1695]
In the citing paper
“An analysis of 2 available US studies showed a 2.75-fold greater risk of motor vehicle accidents when insulin-treated persons were compared with individuals without DM (P = .001), while studies from outside the United States demonstrated no significant difference in accident risk.1695”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [1695]
Citations
Cites
1 retracted
Asemi, Z., Khorrami-Rad, A., Alizadeh, S.-A., Shakeri, H., & Esmaillzadeh, A. (2014) · Clinical Nutrition · doi:10.1016/j.clnu.2013.05.015 · Cited by 190 · cited 1×
“[14] was excluded, the pooled standardized mean differences in the T2DM group changed from −0.”
BackgroundRetractedPreferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & for the PRISMA Group (2009) · BMJ · doi:10.1136/bmj.b2535 · Cited by 83,823
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & The PRISMA Group (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000097 · Cited by 64,042 · cited 1×
“The search process and strategy (see Figure 1) of all the 18 included studies are displayed in a flow diagram [36].”
MethodBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement.
(2009) · PubMed Central · Cited by 44,859
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
AFRC, R. F. (1989) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1989.tb05105.x · Cited by 4,149 · cited 1×
“Probiotics were defined primitively by Fuller as live microbial feed supplements that beneficially affect the host, improving its intestinal microbial balance [1].”
BackgroundSystematic reviews: CRD's guidance for undertaking reviews in health care
Tacconelli, E. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70065-7 · Cited by 3,245
Gut Microbiota in Human Adults with Type 2 Diabetes Differs from Non-Diabetic Adults
Larsen, N., Vogensen, F. K., van den Berg, F. W. J., Nielsen, D. S., Andreasen, A. S., Pedersen, B. K., Al-Soud, W. A., Sørensen, S. J., Hansen, L. H., & Jakobsen, M. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009085 · Cited by 2,952 · cited 1×
“One of the possible mechanisms by which this effect occurs is through the impact of probiotics on changing intestinal microbiota [8, 43].”
BackgroundAntioxidants and Prevention of Chronic Disease
WILLCOX, J. K., ASH, S. L., & CATIGNANI, G. L. (2004) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408690490468489 · Cited by 1,188 · cited 1×
“The antioxidant activity of probiotics has been confirmed in a previous experiment [47].”
Result
Research works printed but not linked: 2
- Harisa, 2008, Oral administration of Lactobacillus acidophilus restores nitric oxide level in diabetic rats Basic, Appl Sci, 3, 2963
- RevMan, 2012, Computer Program ] Version Copenhagen : The Nordic Cochrane Centre , The Cochrane Col - laboration, Review Manager
Cited by
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Koutnikova, H., Genser, B., Monteiro-Sepulveda, M., Faurie, J.-M., Rizkalla, S., Schrezenmeir, J., & Clément, K. (2019) · BMJ Open · doi:10.1136/bmjopen-2017-017995 · Cited by 299
Mantegazza, C., Molinari, P., D’Auria, E., Sonnino, M., Morelli, L., & Zuccotti, G. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.08.001 · Cited by 162
Short-chain fatty acids and insulin sensitivity: a systematic review and meta-analysis
Pham, N. H. T., Joglekar, M. V., Wong, W. K. M., Nassif, N. T., Simpson, A. M., & Hardikar, A. A. (2023) · Nutrition Reviews · doi:10.1093/nutrit/nuad042 · Cited by 164
Barengolts, E., Smith, E. D., Reutrakul, S., Tonucci, L., & Anothaisintawee, T. (2019) · Nutrients · doi:10.3390/nu11030671 · Cited by 125
Wang, Z.-B., Xin, S.-S., Ding, L.-N., Ding, W.-Y., Hou, Y.-L., Liu, C.-Q., & Zhang, X.-D. (2019) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2019/3862971 · Cited by 100
“Similar to the previous study on patients with diabetes or other metabolism syndromes [23, 33], probiotics supplementation also significantly reduced TC (SMD [95%CI]; -0.”
Zádori, Z., Király, K. P., Al‐Khrasani, M., & Gyires, K. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108327 · Cited by 99
Neto, M. P. C., Aquino, J. D. S., da Silva, L. D. F. R., Silva, R. D. O., Guimarães, K. S. D. L., de Oliveira, Y., de Souza, E. L., Magnani, M., Vidal, H., & Alves, J. L. D. B. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.020 · Cited by 90
Tabrizi, R., Ostadmohammadi, V., Lankarani, K. B., Akbari, M., Akbari, H., Vakili, S., Shokrpour, M., Kolahdooz, F., Rouhi, V., & Asemi, Z. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.04.003 · Cited by 63
Mahdavi‐Roshan, M., Salari, A., Kheirkhah, J., & Ghorbani, Z. (2022) · Heart Lung and Circulation · doi:10.1016/j.hlc.2021.09.006 · Cited by 80
Ding, L.-N., Ding, W.-Y., Ning, J., Wang, Y., Yan, Y., & Wang, Z.-B. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.770861 · Cited by 49
“Some prospective studies and meta-analyses support the notion that the administration of probiotics could improve glycaemic control (Hu et al., 2017; Wang et al., 2017).”
BackgroundSelf-citationZarezadeh, M., Musazadeh, V., Faghfouri, A. H., Sarmadi, B., Jamilian, P., Jamilian, P., Tutunchi, H., & Dehghan, P. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106397 · Cited by 49
Anwer, M. D. A., & Wei, M. Q. (2024) · Food Science and Biotechnology · doi:10.1007/s10068-024-01630-z · Cited by 54
“They can also reduce pro-inflammatory markers, reactive oxygen species, and insulin resistance (Wang et al., 2017a, 2017b).”
BackgroundMousavi, S. N., Saboori, S., & Asbaghi, O. (2020) · Obesity Medicine · doi:10.1016/j.obmed.2020.100221 · Cited by 42
Naseri, K., Saadati, S., Ghaemi, F., Ashtary‐Larky, D., Asbaghi, O., Sadeghi, A., Afrisham, R., & de Courten, B. V. (2022) · European Journal of Nutrition · doi:10.1007/s00394-022-03012-9 · Cited by 66
Syringe-feeding as a novel delivery method for accurate individual dosing of probiotics in rats
Tillmann, S., & Wegener, G. (2017) · Beneficial Microbes · doi:10.3920/bm2017.0127 · Cited by 32
“Recent studies also suggested a potential clinical use in extraintestinal diseases, such as type II diabetes (Wang et al., 2017), rheumatoid arthritis (Wang et al.”
BackgroundAntidiabetic Effects of Pediococcus acidilactici pA1c on HFD-Induced Mice
Cabello-Olmo, M., Oneca, M., Pajares, M. J., Jiménez, M., Ayo, J., Encío, I., Barajas, M. A., & Araña, M. (2022) · Nutrients · doi:10.3390/nu14030692 · Cited by 34
Kattar, S. A., Jurjus, R. A., Pinon, A., Leger, D. Y., Jurjus, A. R., Boukarim, C., Diab‐Assaf, M., & Liagre, B. (2020) · Cancers · doi:10.3390/cancers12071857 · Cited by 34
“These results are in line with preliminary interventions in humans suggesting that probiotics may improve glucose metabolism, insulin, and HbA1c levels [40,41].”
ResultMa, J., Wang, J., Wan, Y., Wang, S., & Jiang, C. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118815 · Cited by 31
Chenhuichen, C., Cabello-Olmo, M., Barajas, M. A., Izquierdo, M., Ramírez‐Vélez, R., Zambom-Ferraresi, F., & Martínez‐Velilla, N. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111809 · Cited by 27
The role of yoghurt consumption in the management of type II diabetes
Yanni, A. E., Kartsioti, K., & Karathanos, V. Τ. (2020) · Food & Function · doi:10.1039/d0fo02297g · Cited by 29
Salari, A., Mahdavi‐Roshan, M., Kheirkhah, J., & Ghorbani, Z. (2021) · PharmaNutrition · doi:10.1016/j.phanu.2021.100261 · Cited by 29
Setayesh, A., Karimi, M., Karimi, M. A., Pirzad, S., Heydari, M., Asbaghi, O., Davoodi, S. H., & Larijani, B. A. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10644-w · Cited by 27
“These findings are congruent with our results and align with studies conducted by Rittiphairoj et al. [94]and Wang et al. [95].”
Keivanlou, M., Amini‐Salehi, E., Hassanipour, S., Zare, R., Mohammadi‐Vajari, E., Hashemi, M., Salari, A., & Porteghali, P. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998284844240102110559 · Cited by 22
Xu, D., Fu, L., Pan, D., Chu, Y., Feng, M., Lü, Y., Yang, C., Wang, Y., Xia, J., & Sun, G. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2117783 · Cited by 20
“…2016, 2021; Chen et al. 2020; J. Zhang et al. 2019; Tang et al. 2019; Pan et al. 2019; Liu et al. 2019; Han et al. 2019; Peng, Wu, and Chao 2018; Wang et al. 2017; Hu et al. 2017; Zhang, Wu, and Fei 2016; Ruan et al. 2015; Ma et al. 2013; Zhang et al. 2022a, 2022b; Qiu et al. 2022; Huang et al.…”
ResultSelf-citationGut microbiota interventions in type 2 diabetes mellitus: An umbrella review of glycemic indices
Keivanlou, M., Amini‐Salehi, E., Sattari, N., Hashemi, M., Saberian, P., Prabhu, S. V., Javid, M., Mirdamadi, A., Heidarzad, F., Bakhshi, A., et al. (2024) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2024.103110 · Cited by 23
Role of functional foods in the management of diabetes mellitus: a concise review
Kayode, A. A. A., Alabi, G. O., Fabunmi, D. I., & Kayode, O. T. (2023) · Bioactive Molecules and Pharmaceuticals · doi:10.31989/bmp.v2i7.1132 · Cited by 29
“Positive effects of probiotics supplements on fasting blood glucose, HbA1c, and insulin were observed in individuals with T2DM [43] while Akbari & Hendijani [44] reported a significant decrease in fasting blood glucose and Hb1Ac with no effect on insulin levels and insulin resistance.”
InfluentialThe effect of kefir-spirulina on glycemic status and antioxidant activity in hyperglycemia rats
Laela, N., Legowo, A. M., & Fulyani, F. (2021) · Potravinarstvo Slovak Journal of Food Sciences · doi:10.5219/1445 · Cited by 12
“SCFA were thought capable of protecting pancreatic β-cells, increasing enzymatic antioxidant activity, and improving insulin resistance through regulating the expression of tumor necrosis factor-alpha (alpha TNFα) and nuclear factor-kappa B (NF-kB) (Wang et al., 2017).”
BackgroundRezaee, N., Rahmani‐Nia, F., Delfan, M., & Ghahremani, R. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119973 · Cited by 10
Cabello-Olmo, M., Oneca, M., Goñi, S., Urtasun, R., Pajares, M. J., Yavorov-Dayliev, D., Iturria, I., Ayo, J., Encío, I., Barajas, M. A., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26136408 · Cited by 6
Diabetes Mellitus’ta Mikrobiyotanın Rolü ve Hedeflenmesi
Aksoyalp, Z. Ş., & Nacıtarhan, C. (2021) · Turkish Journal of Diabetes and Obesity · doi:10.25048/tudod.711605 · Cited by 2
Probiotics, Prebiotics, and Synbiotics in Human Health
Wells, O. L., Mishra, S. P., & Yadav, H. (2022) · Royal Society of Chemistry eBooks · doi:10.1039/9781839160950-00086 · Cited by 3
Lazarenko, L. M., Melnykova, O., Babenko, L. P., Bubnov, R. V., Beregova, T. V., Falalyeyeva, T. M., & Spivak, M. Y. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-19564-8_14 · Cited by 1
Ramsy, N., & Michail, S. K. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.66050-6
Botanical and Nonbotanical Products for Glucose Lowering
(2021) · American Diabetes Association eBooks · doi:10.2337/9781580407687.ch01
The Role and Targeting of Microbiota in Diabetes Mellitus
Aksoyalp, Z. Ş., & Nacıtarhan, C. (2020) · DergiPark (Istanbul University)
Kattar, S. A. (2020) · theses.fr (ABES) · doi:10.70675/6bb94cb9z0f27z4037za0ffz163c32a2084f · Cited by 1
Metadata
- Authors
- Wang, X., Juan, Q.-F., He, Y.-W., Zhuang, L., Fang, Y.-Y., & Wang, Y.-H.
- Affiliations
- Qinghai University (CN)
- Qinghai University Affiliated Hospital (CN)
- Corresponding author
- Juan, Qi-Fang
- ORCID
- Venue
- Journal of Pediatric Endocrinology and Metabolism
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-05-24
- Volume
- 30
- Issue
- 6
- Pages
- 611-622
- ISSN
- 0334-018X (ISSN-L)
- 2191-0251
- OpenAlex
- W2617248569
- Cited by
- 37
- References
- 49
- Citations by year
- 2025: 2 · 2024: 4 · 2023: 3 · 2022: 9 · 2021: 6 · 2020: 5 · 2019: 4 · 2018: 2 · 2017: 2
- FWCI
- 0.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Pediatric Endocrinology and Metabolism (publishedVersion)
- PubMed (publishedVersion)
- Lanzhou University Institutional Repository (submittedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Natural Antidiabetic Agents Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, diabetes mellitus, type 2 diabetes, HbA1c, blood glucose, insulin, LDL cholesterol, glycemic control, diabetes risk factors
- MeSH terms
- Diabetes Mellitus, Humans, Randomized Controlled Trials as Topic, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.